Tori Rodriguez, MA, LPC, AHC

Contributing Writer

Tori Rodriguez, MA, LPC, AHC, is an Atlanta-based journalist, licensed psychotherapist, and Ayurvedic health coach, creator of the body-positive wellness company Bettie Page Fitness, and author of 2 books – The Little Book of Bettie: Taking a Page from the Queen of Pinups and Bettie Page: The Lost Years. She holds a BS in psychology from Georgia State University and an MA in counseling psychology from the Georgia School of Professional Psychology. Tori has also managed a medical practice and was instrumental in developing Georgia’s multispecialty telemedicine program. Photograph courtesy of Brooklyn Brat Images.

All articles by Tori Rodriguez, MA, LPC, AHC

Features, WD Features

Accelerating and Improving the Diagnosis of Wilson Disease

Tori Rodriguez, MA, LPC, AHC

March 27, 2023

Untreated Wilson disease can eventually result in death, but patients who receive adequate treatment can have a normal lifespan

Synthetic Control Arms Could Facilitate More RCTs in Rare Disease

Tori Rodriguez, MA, LPC, AHC

November 14, 2022

Dr. Rahul Banerjee of the University of Washington discusses the benefits and drawbacks of using synthetic control arms in randomized controlled trials.

Features, SCD Features, Uncategorized

L-Glutamine in Sickle Cell Disease: The Real-World Impact to Date

Tori Rodriguez, MA, LPC, AHC

January 21, 2022

L-glutamine was approved in 2017 to treat acute complications in patients with sickle cell disease, but uptake of and adherence to it have been limited.

CAD Features, Features

Updates on the Treatment of Cold Agglutinin Disease

Tori Rodriguez, MA, LPC, AHC

November 11, 2021

Given the rarity of CAD and lack of comparative trials, treatment plans are primarily based on findings from nonrandomized trials and clinical experience.

Researchers worked to better understand and manage patients with mild or moderate hemophilia, who can be an underrepresented and underserved population.

Features, HEM Features

Treatment Challenges in Mild to Moderate Hemophilia

Tori Rodriguez, MA, LPC, AHC

April 23, 2021

Researchers worked to better understand and manage patients with mild or moderate hemophilia, who can be an underrepresented and underserved population.

Next post in HEM Features

Tori Rodriguez, MA, LPC, AHC

All articles by Tori Rodriguez, MA, LPC, AHC

Accelerating and Improving the Diagnosis of Wilson Disease

Synthetic Control Arms Could Facilitate More RCTs in Rare Disease

L-Glutamine in Sickle Cell Disease: The Real-World Impact to Date

Updates on the Treatment of Cold Agglutinin Disease

Treatment Challenges in Mild to Moderate Hemophilia

Italian Hematologist Urges End to ‘Useless’ Restrictive Diets After Stem Cell Transplants